Monica Morrow

Active 1981–2025

255
Papers
47,437
Citations
108
h-index
244
i10-index

Citations

Citations per year for Monica Morrow1981: 1 citations1984: 1 citations1985: 1 citations1986: 3 citations1987: 4 citations1988: 1 citations1989: 1 citations1991: 2 citations1992: 6 citations1993: 2 citations1994: 1 citations1995: 4 citations1996: 8 citations1997: 6 citations1998: 9 citations1999: 31 citations2000: 72 citations2001: 101 citations2002: 118 citations2003: 117 citations2004: 113 citations2005: 126 citations2006: 146 citations2007: 110 citations2008: 149 citations2009: 142 citations2010: 162 citations2011: 146 citations2012: 153 citations2013: 197 citations2014: 259 citations2015: 271 citations2016: 296 citations2017: 393 citations2018: 332 citations2019: 1,250 citations2020: 1,461 citations2021: 1,408 citations2022: 1,141 citations2023: 951 citations2024: 1,552 citations2025: 644 citations2026: 37 citations1982–1983: no citations, so these years are not shown1990: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,011 citing papers, 27.1% of this breakdownChina: 1,692 citing papers, 11.4% of this breakdownItaly: 883 citing papers, 6% of this breakdownUnited Kingdom: 820 citing papers, 5.5% of this breakdownGermany: 626 citing papers, 4.2% of this breakdownCanada: 485 citing papers, 3.3% of this breakdownNetherlands: 457 citing papers, 3.1% of this breakdownFrance: 431 citing papers, 2.9% of this breakdownAustralia: 367 citing papers, 2.5% of this breakdownSwitzerland: 360 citing papers, 2.4% of this breakdownSpain: 354 citing papers, 2.4% of this breakdownJapan: 305 citing papers, 2% of this breakdown
0%27.1%Other 27.2%

Fields

  • Biochemistry, Genetics and Molecular Biology43.6%
  • Medicine43.3%
  • Immunology and Microbiology3.5%
  • Computer Science2.3%
  • Health Professions1.8%
  • Engineering1.8%
  • Other3.7%

Topics

  • Breast Cancer Treatment Studies13.3%
  • Breast Lesions and Carcinomas6.2%
  • Breast Implant and Reconstruction5.2%
  • Cancer Genomics and Diagnostics2.5%
  • HER2/EGFR in Cancer Research2.3%
  • BRCA gene mutations in cancer2.3%
  • Other68.2%

Coauthors

All papers

Open in search
  1. Breast cancer

    Authors: , , , , - The Lancet 2021 cited by 1,620

  2. Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Joseph A. Sparano, Tanja Španić, Sandra M. Swain, Sergei Tjulandin, Masakazu Toi, Dario Trapani, Andrew Tutt, B. Xu, Giuseppe Curigliano, Nadia Harbeck - Annals of Oncology 2023 cited by 844

  3. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Clifford A. Hudis, James N. Ingle, Jacek Jassem, Zefei Jiang, Per Karlsson, Sibylle Loibl, Monica Morrow, Moïse Namer, C. Kent Osborne, Ann H. Partridge, Frédérique Penault‐Llorca, Charles M. Perou, Martine Piccart, Kathleen I. Pritchard, Emiel J. Rutgers, Felix Sedlmayer, Semiglazov Vf, Zhi‐Ming Shao, Ian Smith, Beat Thürlimann, Masakazu Toi, Andrew Tutt, Michael Untch, Giuseppe Viale, Toru Watanabe, Nicholas Wilcken, Eric P. Winer, William C. Wood - Annals of Oncology 2013 cited by 3,715

  4. Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis

    Authors: , , , , , , , , , , , , , - JAMA 2017 cited by 1,862

  5. Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Viviana Galimberti, Hebatallah Gamal El Din Mohamed Mahmoud, Judy E. Garber, Michael Gnant, William J. Gradishar, Bahadır M. Güllüoğlu, Nadia Harbeck, Chiun‐Sheng Huang, Jens Huober, André Ilbawi, Zefei Jiang, Steven Johnston, Eun Sook Lee, Sibylle Loibl, Monica Morrow, Ann H. Partridge, Martine Piccart, Philip Poortmans, Aleix Prat, Meredith M. Regan, Isabella Rubio, Hope S. Rugo, Emiel J. Rutgers, Felix Sedlmayer, Vladimir Semiglazov, Hans-Joerg Senn, Zhiming Shao, Tanja Španić, Petra Tesařová, Beat Thürlimann, Sergei Tjulandin, Masakazu Toi, Maureen Trudeau, Nicholas Turner, Inez Vaz Luis, Giuseppe Viale, Toru Watanabe, William P. Weber, Eric P. Winer, Binghe Xu - Annals of Oncology 2021 cited by 803

  6. High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alexandra S. Heerdt, Marc Ladanyi, David M. Hyman, David R. Jones, Monica Morrow, Gregory J. Riely, Howard I. Scher, Charles M. Rudin, Mark E. Robson, Luis A. Díaz, David B. Solit, Alexander M. Aravanis, Jorge S. Reis‐Filho - Nature Medicine 2019 cited by 767

  7. Regulatory T Cells Exhibit Distinct Features in Human Breast Cancer

    Authors: , , , , , , , - Immunity 2016 cited by 704

  8. Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Clifford A. Hudis, James N. Ingle, Jacek Jassem, Zefei Jiang, Per Karlsson, Monica Morrow, Roberto Orecchia, C. Kent Osborne, Ann H. Partridge, Lorena de la Peña, Martine Piccart, Kathleen I. Pritchard, Emiel J. Rutgers, Felix Sedlmayer, Semiglazov Vf, Zhi‐Ming Shao, Ian Smith, Beat Thürlimann, Masakazu Toi, Andrew Tutt, Giuseppe Viale, Gϋnter von Minckwitz, Toru Watanabe, Timothy J. Whelan, Eric P. Winer, Binghe Xu - Annals of Oncology 2015 cited by 1,837

  9. Overview of Breast Cancer Therapy

    Authors: , , , - PET Clinics 2018 cited by 543

  10. Understanding breast cancer complexity to improve patient outcomes: The St Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Giuseppe Curigliano, Jana de Boniface, Suzette Delaloge, A. DeMichele, Carsten Denkert, Gerd Fastner, Florian Fitzal, Prudence A. Francis, H Gamal, Oreste ­Gentilini, Michael Gnant, William J. Gradishar, B. Gulluoglu, Nadia Harbeck, Jörg Heil, Chien Shiun Huang, Jens Huober, Zeping Jiang, Orit Kaidar‐Person, Marleen Kok, Eun‐So Lee, Sherene Loi, S. Loibl, Miguel Martín, Icro Meattini, Monica Morrow, A. H. Partridge, Frédérique Penault‐Llorca, Martine Piccart, Lori J. Pierce, Philip Poortmans, Meredith M. Regan, J. S. Reis-Filho, Isabel T. Rubio, Hope S. Rugo, Emiel J. Rutgers, Cristina Saura, Elżbieta Senkus, Zhi-Ming Shao, Christian F. Singer, Tanja Španič, Beat Thuerlimann, Masakazu Toi, Sara M. Tolaney, Nicholas C. Turner, Andrew Tutt, M.-J. Vrancken Peeters, Toru Watanabe, William P. Weber, Hans Wildiers, B. Xu - Annals of Oncology 2023 cited by 221

  11. De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Chiun‐Sheng Huang, Jens Huober, Hussein Khaled, Jacek Jassem, Zefei Jiang, Per Karlsson, Monica Morrow, Roberto Orecchia, Kent C. Osborne, Olivia Pagani, Ann H. Partridge, K. Pritchard, Jungsil Ro, Emiel J. Rutgers, Felix Sedlmayer, Semiglazov Vf, Zhi‐Ming Shao, Ian Smith, Masakazu Toi, Andrew Tutt, Giuseppe Viale, Toru Watanabe, Timothy J. Whelan, Binghe Xu - Annals of Oncology 2017 cited by 1,255

  12. MRI-based machine learning radiomics can predict HER2 expression level and pathologic response after neoadjuvant therapy in HER2 overexpressing breast cancer

    Authors: , , , , , , , , , , - EBioMedicine 2020 cited by 162

  13. MRI for breast cancer screening, diagnosis, and treatment

    Authors: , , - The Lancet 2011 cited by 442

  14. Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases

    Authors: , , , , , , , , , - Annals of Surgery 2010 cited by 1,254

  15. Nodal Recurrence in Patients With Node-Positive Breast Cancer Treated With Sentinel Node Biopsy Alone After Neoadjuvant Chemotherapy—A Rare Event

    Authors: , , , , , , , , , , , , , , , , , , - JAMA Oncology 2021 cited by 152

  16. A Pilot Study of Preoperative Single-Dose Ipilimumab and/or Cryoablation in Women with Early-Stage Breast Cancer with Comprehensive Immune Profiling

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2016 cited by 224

  17. Comparison of 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma

    Authors: , , , , , , , , , - Journal of Nuclear Medicine 2015 cited by 143

  18. Axillary Nodal Management Following Neoadjuvant Chemotherapy

    Authors: , - JAMA Oncology 2016 cited by 255

  19. How Often Does Neoadjuvant Chemotherapy Avoid Axillary Dissection in Patients With Histologically Confirmed Nodal Metastases? Results of a Prospective Study

    Authors: , , , , , , , , , , , , , - Annals of Surgical Oncology 2016 cited by 309

  20. Omission of Axillary Dissection Following Nodal Downstaging With Neoadjuvant Chemotherapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mahmut Müslümanoğlu, María del Rosario Cueva Pérez, Marcelo Chávez Díaz, Martin Heidinger, Mathias K. Fehr, Mattea Reinisch, Mustafa Tükenmez, Nadia Maggi, Nicola Rocco, Nina Ditsch, Oreste ­Gentilini, Régis Resende Paulinelli, Sebastián Solé Zarhi, Sherko Küemmel, S. Bruz̆as, Simona Di Lascio, Tamara K. Parissenti, Tanya L. Hoskin, Uwe Güth, Valentina Ovalle, Christoph Tausch, Henry M. Kuerer, Abigail S. Caudle, Jean-François Boileau, Judy C. Boughey, Thorsten Kühn, Monica Morrow, William P. Weber - JAMA Oncology 2024 cited by 86

  21. Is Low-Volume Disease in the Sentinel Node After Neoadjuvant Chemotherapy an Indication for Axillary Dissection?

    Authors: , , , , , , , - Annals of Surgical Oncology 2018 cited by 162

  22. Obesity promotes breast epithelium DNA damage in women carrying a germline mutation in BRCA1 or BRCA2

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2023 cited by 55

  23. The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women

    Authors: , , , , , , , , , , , , , , - JAMA 1999 cited by 1,881

  24. Risk Factors and Racial and Ethnic Disparities in Patients With Breast Cancer–Related Lymphedema

    Authors: , , , , , , , , - JAMA Oncology 2022 cited by 102